Subcutaneous Injection
Subcutaneous injection is the preferred route for Melanotan II due to its high systemic bioavailability and direct activation of melanocortin receptors, which are responsible for increased melanin production and libido enhancement [Doc 1, Doc 2]. This method involves injecting the peptide under the skin, typically in areas with sufficient subcutaneous fat like the abdomen or thigh [Doc 3]. The injection is usually performed with an insulin syringe, and users are advised to rotate injection sites to avoid tissue irritation [Doc 1]. A typical protocol starts with a low dose of 0.25 mg daily, gradually increasing to a maximum of 1 mg daily over several days to minimize side effects such as nausea and flushing [Doc 2].
| Phase / Protocol | Dosage | Frequency |
|---|---|---|
| Days 1-3 | 0.25 mg | daily |
| Days 4-7 | 0.5 mg | daily |
| Day 8+ | 1 mg | daily |
